tiprankstipranks
Trending News
More News >
Rohto Pharmaceutical Co Ltd (RPHCF)
OTHER OTC:RPHCF
US Market

Rohto Pharmaceutical Co (RPHCF) Financial Statements

Compare
3 Followers

Rohto Pharmaceutical Co Financial Overview

Rohto Pharmaceutical Co's market cap is currently $3.79B. The company's EPS TTM is $0.16484799; its P/E ratio is 15.40; and it has a dividend yield of 1.70%. Rohto Pharmaceutical Co is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $0.28. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 308.63B¥ 270.84B¥ 238.66B¥ 199.65B¥ 181.05B
Gross Profit¥ 169.38B¥ 157.29B¥ 137.42B¥ 116.49B¥ 106.73B
Operating Income¥ 38.47B¥ 40.05B¥ 33.96B¥ 29.35B¥ 22.99B
EBITDA¥ 56.42B¥ 50.40B¥ 42.34B¥ 35.81B¥ 28.61B
Net Income¥ 31.00B¥ 30.94B¥ 26.38B¥ 21.13B¥ 16.74B
Balance Sheet
Cash & Short-Term Investments¥ 77.16B¥ 89.21B¥ 79.95B¥ 72.79B¥ 52.96B
Total Assets¥ 421.88B¥ 346.18B¥ 309.68B¥ 274.63B¥ 225.79B
Total Debt¥ 50.22B¥ 10.49B¥ 11.69B¥ 21.38B¥ 8.10B
Net Debt¥ -26.94B¥ -78.72B¥ -68.26B¥ -51.41B¥ -44.87B
Total Liabilities¥ 150.43B¥ 99.14B¥ 94.60B¥ 90.80B¥ 69.18B
Stockholders' Equity¥ 260.10B¥ 246.32B¥ 209.57B¥ 178.28B¥ 155.91B
Cash Flow
Free Cash Flow¥ 27.84B¥ 25.33B¥ 21.02B¥ 15.92B¥ 9.70B
Operating Cash Flow¥ 36.92B¥ 34.24B¥ 30.92B¥ 27.25B¥ 20.01B
Investing Cash Flow¥ -89.17B¥ -16.32B¥ -13.18B¥ -16.41B¥ -10.24B
Financing Cash Flow¥ 35.32B¥ -13.78B¥ -16.20B¥ 3.47B¥ -2.35B
Currency in JPY

Rohto Pharmaceutical Co Earnings and Revenue History

Rohto Pharmaceutical Co Debt to Assets

Rohto Pharmaceutical Co Cash Flow

Rohto Pharmaceutical Co Forecast EPS vs Actual EPS